Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Alagraf 0.5 Capsule

Prescription Icon
Prescription Required

Marketer

Alacris Healthcare Pvt Ltd

Salt Composition

Tacrolimus (0.5mg)

Overview Alagraf 0.5 Capsule

Post-transplant, Alagraf 0.5 Capsules, used in conjunction with other medications, help prevent organ rejection (e.g., liver, kidney, heart). This immunosuppressant works by suppressing the immune system's attack on the new organ. Dosage and frequency of Alagraf 0.5 Capsules vary based on transplant type, body weight, and other medications; strictly adhere to your physician's instructions. Administer on an empty stomach, at least one hour prior to or two hours after eating. Consistent use is crucial for optimal results; discontinuation increases rejection risk. Alagraf 0.5 Capsules can cause or exacerbate diabetes and kidney issues, requiring immediate medical attention. Other possible side effects include tremors, infections, hypertension, headaches, and sleep disturbances. Report persistent or worsening side effects to your doctor. Immunosuppression increases infection susceptibility. Inform your doctor about pre-existing conditions like kidney, liver, or heart disease, diabetes, or hypertension, and all other medications (especially those for infections, pain, or arthritis), as interactions may occur. Minimize sun and UV exposure due to increased skin cancer risk. Effective contraception is advised for both men and women. Use during pregnancy or breastfeeding is generally discouraged unless medically necessary. Regular medical checkups, including frequent blood pressure monitoring, are essential throughout treatment.

Uses of Alagraf 0.5 Capsule

Avert organ rejection in transplant recipients.

Major Benefits of Alagraf 0.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Alagraf 0.5 Capsule on an empty stomach.

Common Side effects of Alagraf 0.5 Capsule:

  • High blood pressure
  • Increased glucose level in blood
  • Kidney damage
  • Insomnia (difficulty in sleeping)
  • Tremors
  • Headache
  • Abnormal liver function tests
  • Infection

How to use Alagraf 0.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Alagraf 0.5 Capsule on an empty stomach.

How Alagraf 0.5 Capsule works:

Following organ transplantation (such as liver, kidney, or heart), Alagraf 0.5 Capsule, an immunosuppressive agent, diminishes the body's immune reaction. This facilitates the body's acceptance of the transplanted organ.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Alagraf 0.5 Capsules is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Alagraf 0.5 Capsule during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Alagraf 0.5 Capsule while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Alagraf 0.5 Capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Alagraf 0.5 Capsule cautiously. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Alagraf 0.5 Capsule cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Alagraf 0.5 Capsule :

Should you forget a dose of Alagraf 0.5 Capsule, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alagraf 0.5 Capsule

LabelValue
Type of Compound Large-ring lactone antibiotics
Addictive None.
Medication Classification Cancer therapeutics

FAQs on Alagraf 0.5 Capsule

Alagraf 0.5 Capsules are macrolide antibiotics primarily administered post-organ transplantation. Their immunosuppressant action contributes to the prevention of organ rejection following kidney, heart, or liver transplants.
Concurrent use of Alagraf 0.5 Capsule and live attenuated vaccines is contraindicated. This includes, but is not limited to, measles, mumps, rubella, BCG, yellow fever, chickenpox, and typhoid vaccines. Oral polio vaccine and intranasal influenza vaccine should also be avoided during Alagraf 0.5 Capsule treatment.
Alagraf 0.5 Capsule is contraindicated in individuals with allergies to its components, compromised immunity, hypertension, or renal impairment. Its use should be avoided by pregnant or lactating women, and those anticipating administration of live vaccines, such as the MMR vaccine.
Consult your physician if you are pregnant, have allergies, a chronic infection, hyperglycemia, or hypertension. Disclosure of high potassium levels, immunodeficiency, and any past, current, or planned live vaccinations is also necessary.
This medication weakens the immune system, raising the likelihood of infections. Furthermore, Alagraf 0.5 Capsule may, in certain instances, elevate the risk of developing cancers such as skin and lymph node (lymphoma) cancers. Its use diminishes the body's capacity to combat infections. Physician consultation is advised prior to commencing treatment and if any signs of infection appear, including fever, sweating, chills, cough, influenza-like symptoms, muscle pain, or warm, red, or tender skin areas.
Alagraf 0.5 Capsules are not considered a controlled substance due to their lack of abuse potential. Controlled substances, by definition, possess a risk of misuse and therefore require authorization from both medical professionals and regulatory bodies.
Alagraf 0.5 Capsule
142
MRP 165
13% off